Systemic characterization of aging-related phenotypes induced by wild-type and G2019S LRRK2 in Caenorhabditis elegans.

Chun Li, Fu-Yi Shi, Xuan-Xuan He, Shi-Ying Xiong, Long Gu, Gui-Sheng Wu, Pan-Pan Hou, Chen Huang, Huai-Rong Luo

Clinical Trial Research Center, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, China; Dr. Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Mechanism and Quality of Chinese Medicine & Faculty of Chinese Medicine, Macau University of Science and Technology, Taipa, Macau, China; Key Laboratory of Luzhou City for Aging Medicine, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, China; Central Nervous System Drug Key Laboratory of Sichuan Province, Luzhou, Sichuan, China. · pubmed

Paper

Abstract

Leucine-rich repeat kinase 2 (LRRK2), initially identified as a gene implicated in Parkinson's disease, is increasingly recognized for its influence on aging and associated disorders. However, its systemic roles in biological aging remain poorly understood.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper investigates the systemic effects of LRRK2 on aging-related phenotypes in C. elegans. This research is relevant as it explores the biological mechanisms underlying aging, potentially contributing to our understanding of aging processes and age-related diseases.

Author of this paper? Send a correction.